Jason Fuller

Jason Fuller

Corporate Officer/Principal chez
Massachusetts Institute of Technology
48 ans
Health Technology
Finance
Consumer Services

Profil

Jason Fuller, Ph.D., is a Partner on the Therapeutics team and joined the Firm in 2021.
Prior to Deerfield, Dr. Fuller was an investor at New Enterprise Associates (NEA), where he co-managed several investments in therapeutics, as well as in tools and diagnostics.
Previous to NEA, he served as Head of Corporate Development at Jounce Therapeutics, one of several company formation projects he helped initiate in his role as Principal at Third Rock Ventures before joining Jounce.
Dr. Fuller holds a B.S.
in Chemical Engineering from Michigan State University, an M.Phil.
from Cambridge University, and a Ph.D.
in Chemical Engineering from the Massachusetts Institute of Technology, where he completed his degree in the lab of Robert Langer

Postes actifs de Jason Fuller

SociétésPosteDébut
Corporate Officer/Principal 07/04/2011
Private Equity Investor 01/01/2014
Private Equity Investor 01/01/2021

Anciens postes connus de Jason Fuller

SociétésPosteFin
GALERA THERAPEUTICS, INC. Directeur/Membre du Conseil 09/06/2020
Directeur/Membre du Conseil -
JOUNCE THERAPEUTICS, INC. Fondateur -
SAGIMET BIOSCIENCES INC. Directeur/Membre du Conseil -
3M COMPANY Corporate Officer/Principal -
Voir l'expérience en détail de Jason Fuller

Formation de Jason Fuller

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

97

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées12

Health Technology

Producer Manufacturing

Health Technology

Health Technology

Consumer Services

Consumer Services

Finance

Finance

Finance

Health Technology

Health Technology

Finance

  1. Bourse
  2. Insiders
  3. Jason Fuller
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT